Who is sponsoring NCT03648060?

NCT03648060 is sponsored by Sword Health, SA.

What drugs are being tested in NCT03648060?

Interventions in NCT03648060: Digital kinematic biofeedback system.

What condition does NCT03648060 study?

NCT03648060 studies Hip Osteoarthritis, Knee Osteoarthritis.

Is NCT03648060 still recruiting?

NCT03648060 is currently completed. Last updated 22 October 2020.

Last reviewed 2020-10-22 · How we verify

NCT03648060

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Efficacy of a Digital Biofeedback System for Home-based Rehabilitation After Total Joint Replacement

Completed NA Last updated 22 October 2020

What this trial tests

NA trial testing Digital kinematic biofeedback system in Hip Osteoarthritis in 88 participants. Completed in 15 May 2020.

Timeline

8 October 2018

Primary endpoint
15 May 2020

15 May 2020

Quick facts

Lead sponsor	Sword Health, SA
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	88
Start date	8 October 2018
Primary completion	15 May 2020
Estimated completion	15 May 2020
Sites	1 location across Portugal

Drugs / interventions tested

Digital kinematic biofeedback system

Conditions studied

Hip Osteoarthritis — all drugs for Hip Osteoarthritis →
Knee Osteoarthritis — all drugs for Knee Osteoarthritis →

Sponsor

Sword Health, SA

Who can join

18 and older, any sex, with Hip Osteoarthritis or Knee Osteoarthritis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study was designed to assess the efficacy of a home-based rehabilitation program using a digital kinematic biofeedback system after total hip or knee replacement. This is a single-arm prospective study. Patients will be enrolled pre-operatively and will perform an 8-week rehabilitation program starting between day 7 and 10 after surgery. This program will consist of rehabilitation sessions performed independently by the patient at under remote monitoring from a physical therapist. Outcomes will be measured at baseline, 4 weeks into the rehabilitation program and at the end of the program. The primary outcome is the change in patient performance measure through the Timed-up-and-Go (TUG) test in comparison with the pre-operative score. Secondary outcomes will be measured in terms of: a) patient reported outcomes (Hip or Knee Osteoarthritis Outcome Score) and b) range of motion of the relevant joint (hip or knee).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Hip Osteoarthritis

Currently open trials in the same condition.

NCT07330999 — Three Variants of the PENG Block With and Without Perineural Adjuvants in Older Adults · NA · recruiting
NCT07327931 — PENG Block Variants With Dexamethasone and Dexmedetomidine in Older Adults · NA · recruiting
NCT07288983 — PENG Block vs Suprainguinal FICB vs Lumbar ESPB for Analgesia After Hip Surgery · NA · recruiting
NCT07327372 — PENG Block With Dexmedetomidine in Older Adults · NA · recruiting
NCT07347041 — Clinical Study of Myofascial Trigger Points(MTrPs) Injection in the Treatment of Hip Osteoarthritis(OA) · NA · recruiting

Other Sword Health, SA trials

Trials by the same sponsor.

NCT05417685 — Digital Care Programs for Musculoskeletal Health · enrolling by invitation
NCT04636528 — Digital Versus Conventional Physical Therapy for Chronic Shoulder Tendinopathy · NA · completed
NCT04808141 — Digital Care Program for Chronic Low Back Pain · NA · completed
NCT04401683 — Home-based Exercise Rehabilitation With a Novel Digital Biofeedback System for Chronic Low Back Pain · NA · withdrawn
NCT04092946 — Digital Home-based Rehabilitation for Musculoskeletal Disorders · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03648060 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Sword Health, SA
Last refreshed: 22 October 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03648060.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing